SLC7A6OS and colorectal carcinoma: IWR-1, as a Wnt/β-catenin inhibitor, exhibited strong potentials to suppress CRC cell invasion and metastasis, especially in terms of suppressing migration, invasion, EMT, and MMP activities of CRC cells.